<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15207-bib-0012">
 <mixed-citation publication-type="journal" id="bph15207-cit-0013">
  <string-name>
   <surname>Chappell</surname>, 
   <given-names>M. C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Marshall</surname>, 
   <given-names>A. C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Alzayadneh</surname>, 
   <given-names>E. M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Shaltout</surname>, 
   <given-names>H. A.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Diz</surname>, 
   <given-names>D. I.</given-names>
  </string-name> (
  <year>2014</year>). 
  <article-title>Update on the angiotensin converting enzyme 2‐angiotensin (1‐7)‐MAS receptor axis: Fetal programing, sex differences, and intracellular pathways</article-title>. 
  <source xml:lang="en">Front Endocrinol (Lausanne)</source>, 
  <volume>4</volume>, 
  <fpage>201</fpage>
  <pub-id pub-id-type="doi">10.3389/fendo.2013.00201</pub-id>
  <pub-id pub-id-type="pmid">24409169</pub-id>
 </mixed-citation>
</ref>
